Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06546670
What this trial is testing

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals 161
Early research (Phase 1)Study completedNCT03935633
What this trial is testing

Short-term Clinical Study of CN128 in Thalassemia Patients

Who this might be right for
Thalassemia
Hangzhou Zede Pharma-Tech Co., Ltd. 16
Early research (Phase 1)Study completedNCT03926819
What this trial is testing

Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

Who this might be right for
Anemia, Sickle Cell
Hillhurst Biopharmaceuticals, Inc. 20
Not applicableStudy completedNCT04802629
What this trial is testing

Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.

Who this might be right for
Preterm BirthOxygen ToxicityFetal Hemoglobin
Medical University of Graz 50
Large-scale testing (Phase 3)Looking for participantsNCT06975865
What this trial is testing

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Who this might be right for
Sickle Cell Disease
Sanofi 192
Testing effectiveness (Phase 2)Active Not RecruitingNCT06421636
What this trial is testing

Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

Who this might be right for
Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Regeneron Pharmaceuticals 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05567458
What this trial is testing

Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.

Who this might be right for
Beta-thalassemia
Bristol-Myers Squibb 94
Large-scale testing (Phase 3)Study completedNCT01395199
What this trial is testing

Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major

Who this might be right for
ThalassemiaIron Overload
University of Campinas, Brazil 62
Large-scale testing (Phase 3)Ended earlyNCT03573882
What this trial is testing

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

Who this might be right for
Sickle Cell Disease
Pfizer 179
Not applicableStudy completedNCT00874172
What this trial is testing

Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy

Who this might be right for
Sickle Cell Anemia
Assistance Publique - Hôpitaux de Paris 176
Not applicableUnknownNCT03352986
What this trial is testing

Substudy of CADRE: for People With Extreme Phenotype: BIOCADRE

Who this might be right for
Sickle Cell Disease
Cardiologie et Développement 300
Post-approval studies (Phase 4)UnknownNCT00103753
What this trial is testing

Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major

Who this might be right for
Beta-Thalassemia
Royal Brompton & Harefield NHS Foundation Trust 65
Testing effectiveness (Phase 2)Ended earlyNCT00350844
What this trial is testing

Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension

Who this might be right for
Sickle Cell DiseasePulmonary Hypertension
Ann & Robert H Lurie Children's Hospital of Chicago 6
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableLooking for participantsNCT07194070
What this trial is testing

A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

Who this might be right for
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC 175
Not applicableStudy completedNCT03755128
What this trial is testing

Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn

Who this might be right for
Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)Erythroblastosis, Fetal
Janssen Research & Development, LLC 17
Not applicableUnknownNCT05214105
What this trial is testing

The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia

Who this might be right for
Sickle Cell DiseaseKidney Diseases, Chronic
University of Tennessee 400
Not applicableLooking for participantsNCT07188766
What this trial is testing

Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis

Who this might be right for
SCDVaso Occlussive Crisis
Imam Abdulrahman Bin Faisal University 394
Not applicableUnknownNCT03498105
What this trial is testing

Utility of the Cardiac Electrical BiomarkerDisease

Who this might be right for
Acute Chest Syndrome
Joanne Turner 800
Post-approval studies (Phase 4)Study completedNCT03992001
What this trial is testing

Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients

Who this might be right for
Thalassemia Major
Università degli Studi di Ferrara 55
Next Page